Objective To explore the value of nerve trunk stimulation in the rehabilitation of lower limb function in the patients with cerebral apoplexy at convalescence stage. Methods According the random number table

the patients with the lower limb dysfunction of cerebral apoplexy at convalescence stage were divided into a control group and a treatment group

42 cases in each group. The drug therapy and the routine rehabilitation training were provided in the two groups. Additionally

in the treatment group

the nerve trunk stimulation therapy was adopted

in which

Chize(LU5

stimulating point of radial nerve)

Neiguan(PC6

stimulating point of median nerve)

Xiaohai(SI8

stimulating point of ulnar nerve) were selected. In the control group

acupuncture intervention was supplemented. Before and after treatment

the peak torque(PT) of the lower flexor-extensor muscle of the knee joint

gait parameters

the score of the modified Ashworth spasm scale(MAS)

the score of Fugl-Meyer motor assessment(FMA) and the score of Fugl-Meyer balance scale(FBS) were recorded. Results After the treatment

the PT of the lower flexor-extensor muscle of the knee joint

the scores of FMA and FBS

the step speed and frequency were all increased

the score of MAS and the difference in the stride between the left and the right were decreased as compared with those before treatment(P<0.01). After the treatment

The PT of the lower flexor-extensor muscle of the knee joint

the scores of FMA and FBS

the step speed and frequency in the treatment group were higher than those in the control group(P<0.01). The score of MAS and the difference in the stride between the left and the right in the treatment group were lower than those in the control group(P<0.01). Conclusion Nerve trunk stimulation therapy quite effectively increases the muscle strength and relieves the muscle tension as well as improves the motor function

the balance and the walking pattern of the lower limbs. This therapy is significantly valuable in the rehabilitation of the lower limbs in the patients with cerebral apoplexy at convalescence stage.